Optimizing Vaginitis Diagnosis to Reduce Health Care Costs in Nonpregnant Women Utilizing Molecular Diagnostics
- 1 August 2022
- journal article
- research article
- Published by Mary Ann Liebert Inc in Population Health Management
- Vol. 25 (4), 449-454
- https://doi.org/10.1089/pop.2022.0096
Abstract
Vaginitis is a common condition that affects women of reproductive age. Early and accurate diagnosis and identification of the causative agents (ie, fungi, protozoa, bacterial species, etc.) help to avoid incorrect treatment and subsequent visits that add costs and therapies, which increase overall health care utilization. A prior study by Kong et al presented a cost analysis demonstrating that women who received a nucleic acid amplification test (NAAT) on the day of their vaginitis diagnosis had significantly lower 12-month follow-up costs than women who received a direct probe (DP) test or women who received clinical evaluation without the use of a molecular test. This prior analysis included pregnant women, which may have influenced the findings. The objective of this analysis is to determine whether the exclusion of pregnant women from the study cohort impacts the previously observed NAAT cost-savings results. The current analysis adds evidence that nonpregnant women diagnosed with NAAT at their initial visit have significantly lower 12-month overall health care costs than women evaluated through DP or other clinical methods.Keywords
This publication has 12 references indexed in Scilit:
- Vaginitis in Nonpregnant PatientsObstetrics & Gynecology, 2020
- High Global Burden and Costs of Bacterial Vaginosis: A Systematic Review and Meta-AnalysisSexually Transmitted Diseases, 2019
- Health care utilization and costs following amplified versus non-amplified molecular probe testing for symptomatic patients with suspected vulvovaginitis: a US commercial payer populationClinicoEconomics and Outcomes Research, 2019
- Multicenter study establishing the clinical validity of a nucleic-acid amplification–based assay for the diagnosis of bacterial vaginosisDiagnostic Microbiology and Infectious Disease, 2018
- Acute otitis media, antimicrobial prescriptions, and medical expenses among children in the United States during 2011–2016Vaccine, 2018
- Diagnostic Performance of a Molecular Test versus Clinician Assessment of VaginitisJournal of Clinical Microbiology, 2018
- Recurrent vulvovaginitisBest Practice & Research Clinical Obstetrics & Gynaecology, 2014
- Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United StatesBMC Ophthalmology, 2009
- “Shotgun” versus sequential testingJournal of General Internal Medicine, 2005
- Pregnancy Complications Associated With Bacterial Vaginosis and Their Estimated CostsInfectious Diseases in Obstetrics and Gynecology, 1995